Detalhe da pesquisa
1.
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Lancet
; 402(10404): 798-808, 2023 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451295
2.
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial.
Lancet
; 400(10358): 1117-1129, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099927
3.
Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 395(10236): 1558-1568, 2020 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32416781
4.
Gebrauch von Komplementärmedizin bei Patienten mit metastasierendem Melanom unter Therapie mit Ipilimumab innerhalb einer klinischen Studie.
J Dtsch Dermatol Ges
; 14(5): 508-13, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27119473
5.
Use of complementary medicine in metastatic melanoma patients treated with ipilimumab within a clinical trial.
J Dtsch Dermatol Ges
; 14(5): 508-13, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27119474
6.
Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma.
J Transl Med
; 13: 351, 2015 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26541511
7.
Increased level of circulating U2 small nuclear RNA fragments indicates metastasis in melanoma patients.
Clin Chem Lab Med
; 53(4): 605-11, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25741740
8.
[Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma]. / Vogt-Koyanagi-Harada-artige Uveitis unter Immun-Checkpoint-Inhibitor-Therapie beim metastasierten malignen Melanom.
Ophthalmologe
; 117(5): 467-471, 2020 May.
Artigo
em Alemão
| MEDLINE | ID: mdl-31489479
9.
Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management.
ESMO Open
; 4(3): e000491, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231568
10.
Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients.
Cancer Chemother Pharmacol
; 62(4): 685-8, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18084763
11.
Interdisciplinary management recommendations for toxicity associated with interferon-alfa therapy.
J Dtsch Dermatol Ges
; 6(10): 829-37, 829-38, 2008 Oct.
Artigo
em Inglês, Alemão
| MEDLINE | ID: mdl-18371051
12.
The efficacy of re-challenge with BRAF inhibitors after previous progression to BRAF inhibitors in melanoma: A retrospective multicenter study.
Oncotarget
; 9(76): 34336-34346, 2018 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-30344946
13.
Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial.
Oncotarget
; 8(44): 76029-76043, 2017 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29100289
14.
Dose-dependent treatment benefit in high-risk melanoma patients receiving adjuvant high-dose interferon alfa-2b.
Cancer Biother Radiopharm
; 20(3): 280-9, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15989473
15.
[Erratum to: Vogt-Koyanagi-Harada-like uveitis under immune checkpoint inhibitor treatment for metastasized malignant melanoma]. / Erratum zu: Vogt-Koyanagi-Harada-artige Uveitis unter Immun-Checkpoint-Inhibitor-Therapie beim metastasierten malignen Melanom.
Ophthalmologe
; 117(5): 472-473, 2020 05.
Artigo
em Alemão
| MEDLINE | ID: mdl-31628506
16.
Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma.
PLoS One
; 10(3): e0118564, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25761109
17.
Individualized synthetic peptide vaccines with GM-CSF in locally advanced melanoma patients.
Cancer Biother Radiopharm
; 19(6): 758-63, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15665624
18.
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network.
PLoS One
; 8(1): e53745, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23341990
19.
Age has no significant impact on overall survival and on treatment tolerability in relapsed stage IV cutaneous malignant melanoma patients receiving Cisplatin, Gemcitabine, and Treosulfan.
Am J Clin Oncol
; 34(1): 2-5, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20042970
20.
Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
Cancer Chemother Pharmacol
; 64(5): 901-5, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19229537